These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rethinking molecular similarity: comparing compounds on the basis of biological activity. Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495 [TBL] [Abstract][Full Text] [Related]
4. Reporting data from high-throughput screening of small-molecule libraries. Inglese J; Shamu CE; Guy RK Nat Chem Biol; 2007 Aug; 3(8):438-41. PubMed ID: 17637769 [TBL] [Abstract][Full Text] [Related]
5. High throughput assay technologies for ion channel drug discovery. Zheng W; Spencer RH; Kiss L Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652 [TBL] [Abstract][Full Text] [Related]
6. Scaffold composition and biological relevance of screening libraries. Shelat AA; Guy RK Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770 [TBL] [Abstract][Full Text] [Related]
7. Allosteric agonist modulators. Kenakin T J Recept Signal Transduct Res; 2007; 27(4):247-59. PubMed ID: 17885921 [TBL] [Abstract][Full Text] [Related]
9. Use of high-content analysis for compound screening and target selection. Rausch O IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566 [TBL] [Abstract][Full Text] [Related]
10. Screening for content--the evolution of high throughput. Dove A Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197 [No Abstract] [Full Text] [Related]
11. HTS technologies in biopharmaceutical discovery. Wu G; Doberstein SK Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799 [TBL] [Abstract][Full Text] [Related]
12. Adapting high-throughput screening methods and assays for biocontainment laboratories. Rasmussen L; Tigabu B; White EL; Bostwick R; Tower N; Bukreyev A; Rockx B; LeDuc JW; Noah JW Assay Drug Dev Technol; 2015; 13(1):44-54. PubMed ID: 25710545 [TBL] [Abstract][Full Text] [Related]
14. Applications of self-organizing neural networks in virtual screening and diversity selection. Selzer P; Ertl P J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175 [TBL] [Abstract][Full Text] [Related]
15. An efficient method for the detection and elimination of systematic error in high-throughput screening. Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024 [TBL] [Abstract][Full Text] [Related]
16. Considerations for target validation and industrial approaches. Plata-Salamán CR; Ilyin SE Methods Mol Biol; 2007; 361():299-309. PubMed ID: 17172719 [TBL] [Abstract][Full Text] [Related]
17. Introduction of the high throughput screening system. Li Y Chin Med Sci J; 2001 Sep; 16(3):179-81. PubMed ID: 12899335 [TBL] [Abstract][Full Text] [Related]
18. [High throughput pharmacology for drug discovery]. Ozaki H; Imaizumi Y; Oishi K; Kohama K Nihon Yakurigaku Zasshi; 2001 Sep; 118(3):187-96. PubMed ID: 11577459 [TBL] [Abstract][Full Text] [Related]
19. Learning from the data: mining of large high-throughput screening databases. Yan SF; King FJ; He Y; Caldwell JS; Zhou Y J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181 [TBL] [Abstract][Full Text] [Related]
20. A review of basic principles of fractals and their application to pharmacokinetics. Marsh RE; Riauka TA; McQuarrie SA Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):278-88. PubMed ID: 18551095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]